Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Myogenic Progenitor Cell Lineage Specification by CRISPR/Cas9-Based Transcriptional Activators

Stem Cell Reports(2020)10.1016/j.stemcr.2020.03.026Source: DataRank Database

Myogenic Progenitor Cell Lineage Specification by CRISPR/Cas9-Based Transcriptional Activators is a research paper published in Stem Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 25 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access25 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (22 grants)Impact (FWCI 1.12)OA: goldTopics (95)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Ashish Vankara ORCID,Adarsh R. Ettyreddy ORCID,Joel D. Bohning,Charles A. Gersbach ORCID,Jennifer B. Kwon

Live enrichment

PubMed:32330446 PMC:PMC7221109 OpenAlex:https://openalex.org/W3019444898

National Science Foundation

Grant: EFMA- 1830957

U.S. Army Medical Research Acquisition Activity

Grant: W81XWH-15-1-0469

National Institutes of Health

Grant: UG3-AR075336

National Institutes of Health

Grant: U01EB028901

National Institutes of Health

Grant: R01AR069085

National Institutes of Health

Grant: R21NS103007

National Institutes of Health

Grant: U01AI146356

National Institutes of Health

Grant: R21AR072265

National Institutes of Health

Grant: DP2-OD008586

National Institutes of Health

Grant: UH3TR002142

NIH HHS

Grant: DP2 OD008586

NIGMS NIH HHS

Grant: T32 GM144291

NHLBI NIH HHS

Grant: U01 HL156348

NIAMS NIH HHS

Grant: UG3 AR075336

National Institutes of Health

Grant: 5R21NS103007-02

Enhancing Neuronal Reprogramming with Epigenome Editing

National Institutes of Health

Grant: 1U01AI146356-01

Epigenome Editing Technologies for Treating Diverse Disease

National Science Foundation

Grant: 1830957

EFRI CEE : Engineering Technologies to Determine Causal Relationships Between Chromatin Structure and Gene Regulation

National Institutes of Health

Grant: 5UH3TR002142-04

Systemic Inflammation in Microphysiological Models of Muscle and Vascular Disease

National Institutes of Health

Grant: 1DP2OD008586-01

Engineering Morphogenetic Factors for Enhanced Genetic Reprogramming

National Institutes of Health

Grant: 5R01AR069085-04

CRISPR/Cas9-Based Gene Editing for the Correction of Duchenne Muscular Dystrophy

National Institutes of Health

Grant: 1U01EB028901-01

Microphysiological Human Tissue Systems for Monitoring of Genome Editing Outcomes

National Institutes of Health

Grant: 1R21AR072265-01A1

Combinatorial biomimetic systems to enable high-throughput evaluation and expansion of genome-edited dystrophic muscle stem cells

FWCI

1.12

Citation Percentile

0.8%

Influential Citations

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.cell.com/article/S2213671120301168/pdf

GOLDhttp://www.cell.com/article/S2213671120301168/pdf

publisherhttp://www.cell.com/article/S2213671120301168/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213671120301168?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213671120301168?httpAccept=text/plain

Fields of Study

CRISPR and Genetic EngineeringPluripotent Stem Cells ResearchGenetics, Aging, and Longevity in Model OrganismsBiologyMedicine0301 basic medicine0303 health sciences03 medical and health sciencesAnimalsCRISPR-Cas SystemsCell DifferentiationCell LineageCells, CulturedCellular Reprogramming TechniquesDystrophinEpigenesis, GeneticFemaleGene EditingHEK293 CellsHumansInduced Pluripotent Stem CellsInfant, NewbornMaleMiceMice, Inbred NODMice, SCIDMuscle DevelopmentMyoblastsPAX7 Transcription Factor

MeSH Terms

Cellular Reprogramming TechniquesGene EditingAnimalsCell DifferentiationCells, CulturedFemaleHumansInfant, NewbornMaleDystrophinMice, SCIDMice, Inbred NODCell LineageMuscle DevelopmentMyoblastsEpigenesis, GeneticMicePAX7 Transcription FactorInduced Pluripotent Stem CellsHEK293 CellsCRISPR-Cas Systems

Keywords

BiologyProgenitor cellCRISPRCell biologyCas9Induced pluripotent stem cellCellular differentiationEndogenyTranscription factorStem cellCell fate determinationEmbryonic stem cellTranscriptomeMolecular biologyGeneticsGene expressionGeneBiochemistryDifferentiationmyoblastsmyogenesisSatellite CellsPluripotentIpscsEpigenome EditingGene EditingMaleInduced Pluripotent Stem CellsInfant, NewbornCell DifferentiationMice, SCIDMuscle DevelopmentArticleEpigenesis, GeneticDystrophinMiceHEK293 CellsMice, Inbred NODAnimalsHumansCell LineageCellular Reprogramming TechniquesFemaleCRISPR-Cas SystemsCells, Cultured

Sustainable Development Goals

SDG 0: Good health and well-being